TRDMT1 and cancer: In 2022, it was discovered that FMRP serves as an m5C reader, acting as a coordinator between the m5C writer TRDMT1 and eraser ten-eleven translocation 1 (TET1), and this coordination facilitates mRNA-dependent repair and cell survival in cancer [79].